Expansion of Health Savings Account (HSA)-eligible preventive care medicines and services for chronic illnesses
Date Posted: July 19, 2019
HSA-eligible preventive care benefits expansion for chronic illnesses
The IRS released notice that the list of health savings account (HSA)-eligible preventive care benefits, for those with chronic conditions, has been expanded.
IRS Notice 2019-45, effective July 17, 2019, expands the list of preventive care benefits permitted by a qualifying high-deductible health plan (HDHP) under Section 223 of the Internal Revenue Code. This change, to expand the list of preventive care benefits, applies to plans without a deductible or with a deductible below the applicable minimum deductible for an HDHP.
Here’s what you need to know:
- These medical services and items are limited to specific medical care services or items listed for the associated chronic conditions specified in Notice 2019-45 (see chart below).
- IRS explains its criteria – in consultation with HHS – that each listed service or item, when prescribed for an individual with the related chronic condition is low cost and that it has a high likelihood of preventing exacerbation of the chronic condition and/or developing a secondary condition that requires significantly higher cost treatments.
- Any medical care previously recognized as preventive care for these rules is still treated as preventive care, so while this notice clarifies that benefits for the specified services and items for individuals with the specified chronic conditions listed in the Appendix are preventive care for purposes of section 223(c)(2)(C), it does not treat these services and items as preventive care required to be provided without cost sharing for purposes of section 2713 of the PHS Act.
Notice 2019-45 provides that the following services and items for individuals with the specified chronic conditions listed are treated as preventive care:
Preventive Care for Specified Conditions | For Individuals Diagnosed with |
Angiotensin Converting Enzyme (ACE) inhibitors | Congestive heart failure, diabetes, and/or coronary artery disease |
Anti-resorptive therapy | Osteoporosis and/or osteopenia |
Beta-blockers | Congestive heart failure and/or coronary artery disease |
Blood pressure monitor | Hypertension |
Inhaled corticosteroids | Asthma |
Insulin and other glucose lowering agents | Diabetes |
Retinopathy screening | Diabetes |
Peak flow meter | Asthma |
Glucometer | Diabetes |
Hemoglobin A1c testing | Diabetes |
International Normalized Ratio (INR) testing | Liver disease and/or bleeding disorders |
Low-density Lipoprotein (LDL) testing | Heart disease |
Selective Serotonin Reuptake Inhibitors (SSRIs) | Depression |
Statins | Heart disease and/or diabetes |